CB-5083

· Cleave Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CB-5083, covering 2018-02-27 to 2018-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors [Phase 1]